Bioproduct

New Culture and CJ CheilJedang Enter into Strategic Partnership for Commercial Manufacturing Capacity

Retrieved on: 
星期二, 五月 14, 2024
Partnership, SOSV, CJ, Cheese, Culture, Beer, Food, SAN, Senior, Bioproduct, CSO, Fermentation, Schwan's Company, Manfred von Richthofen, CJ CheilJedang, Strategic planning, Kraft Heinz, ADM, Fine chemical

SAN LEANDRO, Calif., May 14, 2024 /PRNewswire/ -- New Culture, the pioneering animal-free dairy company, announced today a strategic partnership with CJ CheilJedang, the world's largest supplier of bioproducts made from microbial fermentation. The partnership is focused on driving down the cost of New Culture's animal-free casein protein, unlocking commodity pricing including for New Culture's first product, mozzarella for pizzerias.

Key Points: 
  • SAN LEANDRO, Calif., May 14, 2024 /PRNewswire/ -- New Culture, the pioneering animal-free dairy company, announced today a strategic partnership with CJ CheilJedang, the world's largest supplier of bioproducts made from microbial fermentation.
  • "Our partnership with CJ CheilJedang facilitates access to some of the largest and most sophisticated fermentation facilities on the planet to truly transform the dairy industry."
  • "Whether through commercial manufacturing, procurement, or other technical support, this partnership enables the full scope of our expertise to accelerate New Culture's growth and market leadership."
  • This partnership with CJ CheilJedang further strengthens New Culture's manufacturing position and path to profitability, building on the company's previously announced partnership with ADM, the US-based, alternative protein and fermentation leader.

Global Pulp Industry Report 2024: Demand and Production Analysis, Trends and Forecasts 2022-2023 and 2024-2028 - ResearchAndMarkets.com

Retrieved on: 
星期三, 三月 13, 2024
Natural Resources, Manufacturing, Textiles, Packaging, Forest Products, Culture, Growth, Recycling, Printing, Eucalyptus, COVID-19, 3D, Biorefinery, Lignin, Hygiene, Bioproduct, Paper, Population growth, Pulp (paper)

The "Global Pulp Market: Analysis by Demand, Production, Type, End Market, Region, Size and Trends with Impact of COVID-19 and Forecast up to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Pulp Market: Analysis by Demand, Production, Type, End Market, Region, Size and Trends with Impact of COVID-19 and Forecast up to 2028" report has been added to ResearchAndMarkets.com's offering.
  • Global pulp market demand stood at 66.02 million tons in 2022, and is expected to reach 73.84 million tons by 2028.
  • Paper pulp, the fundamental ingredient for paper production, forms the basis for the entire paper-making process.
  • The pulp industry is a global market, and heavily reliant on international trade and economic activity.

The Dismantling of the American Timber Industry: American Loggers Council Warns of Consequences

Retrieved on: 
星期一, 三月 25, 2024
Shift, Wood, Carbon, Boise Cascade, Bioproduct, Georgia-Pacific, Paperboard, Legislation, Clearwater Paper, Aviation biofuel, Congress, RFS, Economic development, Policy, Cutback, Renewable energy, Biomass, Electricity, Roseburg Forest Products, Climate change, Graphic Packaging, Disease, News, Essity, WestRock, Health, Natural gas, Pactiv Evergreen, Environment, Steel, International Paper, EPA, Hydrogen, World Bank, Administration, Government, Medicine

WASHINGTON, March 25, 2024 /PRNewswire-PRWeb/ -- It seems like every time a forest product mill or plant shuts down (monthly if not weekly) it's viewed as a singular isolated incident. But viewed collectively, the cumulative impacts and magnitude become more focused and apparent. The individual incidents are all symptoms of a larger serious condition that diagnosed properly reveals and represents an unhealthy state of the U.S. timber and forest products industries.

Key Points: 
  • Many contributing factors leading to the decline of the U.S. timber and forest products industries are government policy, regulations, restrictions, unfair trade practices, federal timber supply constraints, and incessant litigation.
  • While there has been some new mill construction and expansion, this cannot be assumed to be an equal offset.
  • According to the World Bank, the U.S. imports over $40 billion in wood products from Canada, China and Brazil.
  • Note: Prolonged mill quotas (timber delivery supply limits and restrictions) have been imposed by some southeastern mills reducing volume to levels unable sustain cashflow/debt service for loggers.

EQS-News: 3M FY 23/24:  BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24

Retrieved on: 
星期三, 三月 13, 2024
Bioproduct, BioScience, Enzyme, Research, Investment, Growth, Genomics, Protein, FY, BRAIN, Business, Fine chemical

Adriaan Moelker, CEO BRAIN Biotech AG, states: “Our BioScience segment made a very strong start to the business year.

Key Points: 
  • Adriaan Moelker, CEO BRAIN Biotech AG, states: “Our BioScience segment made a very strong start to the business year.
  • The BRAIN Biotech Holding segment mainly includes personnel expenses and other expenses for Group administration, further development of the BRAIN Biotech Group, stock exchange listing and M&A activities.
  • CFO at BRAIN Biotech AG, Michael Schneiders, takes an optimistic view on the financial year 2023/24: “We aim to continue our organic growth path from the last two years.
  • The BRAIN Biotech Group now targets a revenue range of € 58 million to € 62 million for the new financial year.

EQS-News: Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy

Retrieved on: 
星期三, 一月 17, 2024
Research, Bioproduct, Genomics, Investment, Acquisition, Hereditary angioedema, Enzyme, BioScience, Calendar, Business, Protein, BRAIN, Growth, Fine chemical

January 2024 – BRAIN Biotech AG, a leading provider of integrated solutions for the biologization of industry and parent company of the BRAIN Biotech Group, has published the Group´s financial figures for the fiscal year 2022/23.

Key Points: 
  • January 2024 – BRAIN Biotech AG, a leading provider of integrated solutions for the biologization of industry and parent company of the BRAIN Biotech Group, has published the Group´s financial figures for the fiscal year 2022/23.
  • Expanding enzyme sales within the BioProducts segment demonstrated the main contribution to organic growth.
  • BRAIN Biotech’s One-BioProducts strategy will deliver significant growth and cost synergies within the segment during the coming years.
  • CEO Adriaan Moelker says: “I am very pleased that our growth strategy is developing in the targeted direction with a second consecutive year of sales expansion above market growth.

Global Agri-Food Advancement Partnership (GAAP) Invests in Biotech Startup Proxima Research & Development

Retrieved on: 
星期一, 一月 15, 2024
Technology, Biotechnology, Retail, Food Tech, Health, Alternative Energy, Energy, Pharmaceutical, Research, Wine & Spirits, Agriculture, Natural Resources, Science, Food, Beverage, Development, CSO, Partnership, GAAP, Investment, CAP, Bioproduct, Growth, Oil

Saskatchewan's Global Agri-Food Advancement Partnership (GAAP) is excited to announce the recent close of an undisclosed investment round into Proxima Research and Development – Canada.

Key Points: 
  • Saskatchewan's Global Agri-Food Advancement Partnership (GAAP) is excited to announce the recent close of an undisclosed investment round into Proxima Research and Development – Canada.
  • Proxima has developed proprietary technology to better isolate, characterize, and engineer microbes for applications within agriculture, food, and pharma.
  • CEO of GAAP, Jay Robinson, says "Having Proxima as part of the GAAP portfolio will expand our offering for the Canadian agriculture market.
  • Proxima has a vibrant and diverse research and development program which focuses on the isolation and genetic characterization of microbes with applications in food, biofuel, bioproducts, and pharmaceuticals.

HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China

Retrieved on: 
星期一, 一月 8, 2024
IND, Sale, Research, Norovirus, Vaccine, Disease, Mortality, Virus-like particle, SHE, MD, Doctor of Philosophy, Investigational New Drug, VLP, Bioproduct, Safety, Pharmaceutical industry

HIL-216 includes VLPs for six of the most common norovirus genotypes, including GI.1, GII.2, GII.3, GII.4, GII.6, and GII.17.

Key Points: 
  • HIL-216 includes VLPs for six of the most common norovirus genotypes, including GI.1, GII.2, GII.3, GII.4, GII.6, and GII.17.
  • As part of the exclusive license agreement, Kangh will supply HIL-216 for use in HilleVax’s near-term clinical trials, including a Phase 1 trial that HilleVax expects to initiate in 2024.
  • “Our bivalent norovirus VLP vaccine candidate, HIL-214, remains the most advanced norovirus vaccine candidate in clinical development, and we are on-track to report topline safety and efficacy data in mid-2024 from our ongoing Phase 2b NEST-IN1 trial.
  • Kangh is also eligible to receive a single-digit tiered royalty on net sales outside of Greater China.

American BioCarbon Presents at Economist Impact’s Countdown to COP28

Retrieved on: 
星期五, 十月 6, 2023
Environment, Climate Change, Utilities, Coal, Alternative Energy, Manufacturing, Green Technology, Energy, Agriculture, Natural Resources, Climate change, Sustainable Development Goals, Sustainability, COP28, Greenhouse, Bioproduct, The Economist Group, Carbon, Biodiversity, Rainforest, Acceleration, CORC

American BioCarbon, a pioneering manufacturer of sustainable products derived from sugarcane bagasse, was among a select group of distinguished U.S. and international leaders invited to share their expertise at Economist Impact's 3rd annual Sustainability Week: Countdown to COP28 conference.

Key Points: 
  • American BioCarbon, a pioneering manufacturer of sustainable products derived from sugarcane bagasse, was among a select group of distinguished U.S. and international leaders invited to share their expertise at Economist Impact's 3rd annual Sustainability Week: Countdown to COP28 conference.
  • Economist Impact is part of The Economist Group, a global media company which specializes in international business and world affairs information.
  • American BioCarbon was selected to participate in the panel discussion because of its unique carbon sequestration products, specifically bagasse biochar.
  • In addition to renewable bioproducts, American BioCarbon is certified to sell digital tradable assets called CO2 Removal Certificates (CORCs) through a marketing agreement with Puro.earth.

De-Fossilized Sustainable PE, PP, and PET Conference: Pioneering the Sustainable Polymer Revolution - ResearchAndMarkets.com

Retrieved on: 
星期一, 十月 2, 2023
Sustainability, Chemicals, Plastics, Environment, Manufacturing, Biomass, Plastic, Polymer, Chemical industry, Radical, Bioproduct, PET, Greenhouse gas, GHG, Climate change, Biodegradation, Carbon, Mechanical, Movement, Recycling, Pyrolysis oil, PP, Biofuel, Pyrolysis, Building block, Policy, Conference, Renewable energy, Waste, Incineration

The "De-Fossilized Sustainable PE, PP and PET" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "De-Fossilized Sustainable PE, PP and PET" conference has been added to ResearchAndMarkets.com's offering.
  • The landscape of the Polymer and Chemical industry is undergoing a metamorphosis.
  • The De-Fossilized Sustainable PE, PP, and PET Conference provides an unparalleled platform to engage with this sea change.
  • As the Polymer and Plastics industry is being redefined, the conference invites all stakeholders to be a part of this monumental shift.

TeselaGen Biotechnology Renews Partnership with Joint BioEnergy Institute to Enhance Production of Carbon Neutral Bioproducts

Retrieved on: 
星期二, 九月 26, 2023
Joint BioEnergy Institute, BRC, Sustainability, Great Lakes Bioenergy Research Center, Bioproduct, Biochemistry, Secure, Research, DOE, Lawrence Berkeley National Laboratory, Biofuel, Biology, Protein engineering, Joint, AI, Science and technology in Asia, Gene, JBEI, Synthetic biology, United States Department of Energy, Renewable energy, Fine chemical

PORTOLA VALLEY, Calif., Sept. 26, 2023 /PRNewswire/ -- Today, TeselaGen Biotechnology announces that it is extending their relationship with Joint BioEnergy Institute (JBEI) through 2027 via a new multi-year contract. JBEI, led by Lawrence Berkeley National Laboratory (Berkeley Lab), is one of four U.S. Department of Energy (DOE) Bioenergy Research Centers (BRC) that conduct innovative research on biofuels and bioproducts.

Key Points: 
  • TeselaGen and the Joint BioEnergy Institute (JBEI) have signed a new 5-year contract to add expanded workflow capabilities, extending their relationship through 2027
    PORTOLA VALLEY, Calif., Sept. 26, 2023 /PRNewswire/ -- Today, TeselaGen Biotechnology announces that it is extending their relationship with Joint BioEnergy Institute (JBEI) through 2027 via a new multi-year contract.
  • JBEI, led by Lawrence Berkeley National Laboratory (Berkeley Lab), is one of four U.S. Department of Energy (DOE) Bioenergy Research Centers (BRC) that conduct innovative research on biofuels and bioproducts.
  • TeselaGen and JBEI have been collaborating since 2017 on informatic tools for synthetic biology workflows.
  • Over that time, JBEI has continued to deliver novel scientific advancements and breakthroughs needed to produce renewable, carbon-neutral biofuels from non-food plant fiber.